← Retour au Screener

Sector: Santé
Open in Terminal → ENSGLive chart · Key metrics · News · Smart money

Ensign Group

ENSG Large Cap

Healthcare · Medical Care Facilities

Mis à jour: Aug 2, 2026, 22:14 UTC

154,83 €
-0.37% aujourd'hui
52W: 123,04 € – 189,45 €
52W Low: 123,04 € Position: 47.9% 52W High: 189,45 €

Price Chart

Indicateurs clés

P/E Ratio
27.92x
Cours/Bénéfice
Forward P/E
20.83x
P/E prévisionnel
P/S Ratio
1.89x
Cours/Ventes
EV/EBITDA
20.99x
Valeur d'entreprise/EBITDA
Rend. dividende
0.15%
Rendement annuel du dividende
Cap. boursière
9,0 Md €
Capitalisation boursière
Croissance du CA
17.3%
Croissance du CA sur un an
Marge bénéficiaire
6.9%
Marge nette
ROE
16.97%
Rentabilité des capitaux propres
Beta
0.69
Sensibilité au marché
Positions vendeuses
4.4%
% du flottant vendu à découvert
Volume moyen
830,640
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
5 analysts
Avg. Price Target
191,19 €
+23.48% upside
Target Range
179,89 € – 199,88 €

About the Company

Sector: Healthcare Industry: Medical Care Facilities Country: United States Employees: 46,000 Exchange: NMS

Ensign Group en bref

Ensign Group (ENSG) is currently trading at 154,83 € with a market capitalization of 9,0 Md €. The trailing P/E ratio stands at 27.92x, with a forward P/E of 20.83x. The 52-week range spans from 123,04 € to 189,45 €; the current price is 18.3% below the yearly high. Year-over-year revenue growth stands at +17.3%. The net profit margin stands at 6.9%.

💰 Dividende

Ensign Group pays an annual dividend of 0,23 € per share, representing a yield of 0.15%. The payout ratio stands at 4.04%.

📊 Avis des analystes

5 analystes évaluent Ensign Group (ENSG) au consensus : Acheter. L'objectif de cours moyen est de 191,19 €, soit un potentiel de +23.48% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 179,89 € à 199,88 €.

Ensign Group : la thèse d'investissement en détail

Ensign Group (ENSG) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 17.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 23.48% upside from current levels — analyst sentiment is firmly constructive.

À surveiller

  • The forward P/E of 20.83x is meaningfully below the trailing 27.92x — analysts expect earnings to step up; the next earnings release is the test.
  • The analyst consensus price target implies 23.48% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Rentabilité élevée des capitaux propres (16.97% ROE)
  • Consensus des analystes : Buy
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
144,58 €
+7.09% vs. cours
MM 200 jours
158,87 €
-2.54% vs. cours
Sous le plus haut 52s
−18.3%
189,45 €
Au-dessus du plus bas 52s
+25.8%
123,04 €

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

Risque de marché (Bêta)
0.69 · Défensive
Évolue moins que le marché global
Positions vendeuses
4.4% · Faible
% du flottant vendu à découvert
Dette/Capitaux propres
92.03 · Modéré
Dette totale / capitaux propres

The data points to relatively defensive market behavior.

Trading Data

50-Day MA: 144,58 €
200-Day MA: 158,87 €
Volume: 420,541
Avg. Volume: 830,640
Short Ratio: 1.95
P/B Ratio: 4.22x
Debt/Equity: 92.03x
Free Cash Flow: 244 M €

💵 Dividend Info

Dividend Yield
0.15%
Annual Rate
0,23 €
Payout Ratio
4.04%

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Ensign Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut